SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
XWEL

XWELL, Inc. (NASDAQ:XWEL)

US · Delayed Price · Currency is USD
Consumer Cyclical · Personal Products & Services
$0.41-$0.03 (-5.77%)
 
Market cap
$3.25M
Insider Score
Health Score
Analyst consensus
Listed since
Jul 27, 2010
Website
Market Cap$3.25M-43.8%
Revenue (ttm)$28.28M-7.6%
Net Income-$23.42M-21.1%
EPS-$5.29-27.8%
Shares Out7.93M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume18,886
Open$0.44
Previous Close$0.44
Day's Range$0.40 - $0.50
52-Week Range$0.26 - $2.20
Beta0.94
AnalystsBuy
Price Targetn/a
Earnings DateNov 23, 2026
-1.17% (1D)
No price history available.

About XWEL

XWELL Inc. functions as a health and wellness services provider, primarily operating within airports. The company delivers its diverse offerings through various brands, including XpresSpa, XpresTest, Treat, and HyperPointe. Its core services feature a range of spa treatments such as massages, nail care, and skincare, further complemented by the sale of spa, travel, and general retail merchandise. Beyond relaxation services, XWELL also manages dedicated wellness centers. These facilities provide crucial health diagnostic services, encompassing COVID-19 screening and testing, rapid tests for various communicable diseases like influenza, RSV, and different flu strains (A&B), alongside seasonal flu vaccinations and other medical diagnostic procedures. To enhance accessibility for the traveling public, the company utilizes an integrated digital platform and a tailored retail selection. The organization, headquartered in New York, New York, underwent a name change in October 2022, transitioning from its former identity as XpresSpa Group, Inc. to its current designation, XWELL Inc.

Address
254 West 31st Street, New York City, NY, 10001, US
Market Cap
3 million
Employees
175
Industrial Classification
Personal Products & Services
Financial Health Score
Weak
From XWEL’s reported statements · Q2 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
-5.77%
5 Days
-22.64%
1 Month
-40.02%
6 Months
-71.53%
1 Year
-43.84%

$XWEL stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in XWEL holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by XWEL's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

XWEL Estimated quarterly lobbying spending

Source: U.S. Senate LDA

XWEL Revenue by Segment or Geography

$14.03MTotal
Disaggregation of Revenue$7.14M50.94%
Expected revenue under contract$6.88M49.06%

As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New XWEL patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to XWEL from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in XWEL

VXFVanguard Extended Market ETF$35.41K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from XWEL’s recent data — informational, not investment advice

Generating analysis…

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.